Key facts
- It has raised $53.1M; the latest was PE Growth/Expansion ($29.0M) in Nov 2025.
- Notable investors include Octopus Ventures, Balderton Capital, Sofinnova Partners, EQT Ventures, Silverhorn Investment Advisors — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for myTomorrows
- ·The full record, as it builds
Funding rounds
No funding rounds for myTomorrows are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About myTomorrows
Operator of a healthcare information platform intended to improve access to treatments currently in development. The company's platform gathers information about treatments and provides insight into available treatment options and access to medicines, thereby enabling patients to fulfill their unmet medical needs.
- Sector
- Healthcare
- HQ
- Amsterdam, Netherlands
- Founded
- 2012
- Employees
- 133
- Website
- mytomorrows.com/
- Ownership
- Privately Held (backing)
myTomorrows doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in myTomorrows shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on myTomorrows in its N-PORT filings yet. We sweep new filings monthly.